SWS Medical(SH:688410) Ge Long Hui A P P·2025-09-11 11:48Group 1 - The major shareholder, Dajiankang, plans to reduce its stake in the company by up to 12,852,625 shares, representing a maximum of 4.00% of the total share capital [1] - The reduction will be executed through centralized bidding or block trading within a three-month period starting from October 14, 2025, to January 11, 2026 [1] - The selling price will be determined based on the market price at the time of the reduction [1] Group 2 - The company's director and deputy general manager, Ren Yingxiang, intends to sell up to 249,539 shares, which is no more than 0.08% of the total share capital [1] - This reduction will also take place within the same three-month period from October 14, 2025, to January 11, 2026 [1] - Similar to the major shareholder, the selling price for Ren's shares will be based on the market price at the time of the transaction [1]